Innovative Diagnostic Lab to start receiving and processing FIT samples from 1 August 2019
Due to unforeseen circumstances in machine calibration, FIT sample processing with Innovative Laboratory will commence only on 1 August 2019. Clinics using FIT samples received from Innovative laboratory who wish to submit FIT samples on behalf of clients should send them to Parkway Laboratory between 1 July and 31 July. Patients can continue to mail their FIT samples directly as per current practice, regardless whether the envelopes bear Parkway Laboratory's or Innovative Laboratory's address. Arrangements will be made with SingPost to re-route any FIT samples bearing Parkway Laboratory's address to Innovative Laboratory from 1 August to ensure no operational disruptions for self-mailed kits. New self-addressed return envelops indicating Innovative Laboratory will be distributed following the depletion of the current batch of FIT kits.
We have summarised the details for your reference:
Screenings
| Type of tests
| 7 May 2019 to 30 June 2019 | From 1 – 31 July 2019 | From 1 August 2019 onwards |
| Laboratory assigned | Laboratories assigned | Laboratories
assigned |
Cardiovascular Risk
| Fasting Venous Glucose & Lipids Test
|
Parkway Laboratory
|
Parkway Laboratory Innovative Diagnostic
|
Parkway Laboratory Innovative Diagnostic
|
| Glycated Haemoglobin (HbA1c) + Non-fasting Lipid |
| Repeat Fasting Venous Glucose Test |
| Oral Glucose Tolerance Test (OGTTT) |
Cervical Cancer
| Pap test |
Parkway Laboratory
| Parkway Laboratory
Innovative Diagnostic
| Parkway Laboratory Innovative Diagnostic
|
| HPV-DNA |
| Colorectal Cancer | FIT | Parkway Laboratory BioMedix Singapore | Parkway Laboratory BioMedix Singapore | BioMedix Singapore Innovative Diagnostic |
The FAQ has been updated accordingly. It can be accessed via https://www.primarycarepages.sg/practice-management/moh-national-schemes/screen-for-life-(sfl)